Selective cytotoxicity of ricin a chain immunotoxins towards murine cytomegalovirus-infected cells

被引:11
作者
Barnett, BB [1 ]
Smee, DF [1 ]
Malek, SM [1 ]
Sidwell, RW [1 ]
机构
[1] UTAH STATE UNIV,DEPT ANIM DAIRY & VET SCI,LOGAN,UT 84322
关键词
D O I
10.1128/AAC.40.2.470
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Immunotoxins were constructed by linking immunoglobulins specific for murine cytomegalovirus (MCMV) to deglycosylated ricin A chain. Toxicities toward MCMV-infected and uninfected cells were determined by measuring the inhibition of protein synthesis following a 48-h exposure to immunotoxins commencing 24 h after infection. The 50% inhibitory concentrations ranged from 0.4 to 4 mu g/ml for infected cells and from 22 to 120 mu g/ml for uninfected cells. Selectivity indices ranged from 30 to 157. Control immunotoxins, which were constructed identically except that the immunoglobulin moiety had no specificity toward MCMV antigens, had 50% inhibitory concentrations of 50 and 100 mu g/ml toward infected and uninfected cells, respectively.
引用
收藏
页码:470 / 472
页数:3
相关论文
共 26 条
[1]   SELECTIVE CYTOTOXICITY TOWARDS CYTOMEGALOVIRUS-INFECTED CELLS BY IMMUNOTOXINS CONSISTING OF GELONIN LINKED TO ANTICYTOMEGALOVIRUS ANTIBODY [J].
BARNETT, BB ;
SMEE, DF ;
MALEK, SM ;
SIDWELL, RW .
ANTIVIRAL RESEARCH, 1995, 28 (01) :93-100
[2]   ANTIVIRAL IMMUNOTOXINS - ANTIBODY-MEDIATED DELIVERY OF GELONIN INHIBITS PICHINDE VIRUS-REPLICATION INVITRO [J].
BARNETT, BB ;
BURNS, NJ ;
PARK, KJ ;
DAWSON, MI ;
KENDE, M ;
SIDWELL, RW .
ANTIVIRAL RESEARCH, 1991, 15 (02) :125-138
[3]   FOSCARNET TREATMENT OF CYTOMEGALO-VIRUS RETINITIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
JACOBSON, MA ;
ODONNELL, JJ ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :736-741
[4]   SELECTIVE KILLING OF NORMAL OR NEOPLASTIC B-CELLS BY ANTIBODIES COUPLED TO THE A-CHAIN OF RICIN [J].
KROLICK, KA ;
VILLEMEZ, C ;
ISAKSON, P ;
UHR, JW ;
VITETTA, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5419-5423
[5]   GANCICLOVIR FOR THE TREATMENT AND SUPPRESSION OF SERIOUS INFECTIONS CAUSED BY CYTOMEGALOVIRUS [J].
LASKIN, OL ;
CEDERBERG, DM ;
MILLS, J ;
ERON, LJ ;
MILDVAN, D ;
SPECTOR, SA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (02) :201-207
[6]  
LAURENT G, 1986, BLOOD, V67, P1680
[7]   SELECTIVE KILLING OF HIV-INFECTED CELLS BY ANTI-GP120 IMMUNOTOXINS [J].
MATSUSHITA, S ;
KOITO, A ;
MAEDA, Y ;
HATTORI, T ;
TAKATSUKI, K .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (02) :193-203
[8]   THE CAUSES OF DEATH IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A CLINICAL AND PATHOLOGICAL-STUDY WITH EMPHASIS ON THE ROLE OF PULMONARY-DISEASES [J].
MCKENZIE, R ;
TRAVIS, WD ;
DOLAN, SA ;
PITTALUGA, S ;
FEUERSTEIN, IM ;
SHELHAMER, J ;
YARCHOAN, R ;
MASUR, H .
MEDICINE, 1991, 70 (05) :326-343
[9]   RIBOSOME INACTIVATION BY TOXIC LECTINS ABRIN AND RICIN - KINETICS OF ENZYMIC ACTIVITY OF TOXIN A-CHAINS [J].
OLSNES, S ;
FERNANDEZPUENTES, C ;
CARRASCO, L ;
VAZQUEZ, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1975, 60 (01) :281-288
[10]  
PINCUS SH, 1991, J IMMUNOL, V146, P4315